Inhibition of ABC transporters by low-molecular weight compounds has been extensively investigated in cancer patients; however, the clinical results have been disappointing.
Inhibicija ABC transportera dejstvom jedinjenja niske molekulske težine je bila ekstenzivno izučavana kod obolelih od raka; međutim, klinički rezultati su bili razočaravajući.